Arkolith/Insider Trading/CRBP/Form 4

Moran Sean F.

Chief Financial OfficerCorbus Pharmaceuticals Holdings, Inc. (CRBP) · full profile →Form 4 · filed Jun 18, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$864K
Net Open-Market Flow
-$864K
Transactions
12
8 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 18, 2024Option exercise(M)2K$30.00$59K51K
Jun 18, 2024Sell(S)2K$42.12$82K49K
Jun 17, 2024Sell(S)7K$46.77$315K49K
Jun 17, 2024Option exercise(M)7K$14.10$95K55K
Jun 14, 2024Option exercise(M)2K$30.00$47K50K
Jun 14, 2024Sell(S)8K$49.87$388K49K
Jun 14, 2024Sell(S)2K$49.87$78K49K
Jun 14, 2024Option exercise(M)8K$4.26$33K56K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 18, 2024Option exercise(M)2K—$00
Jun 17, 2024Option exercise(M)7K—$011K
Jun 14, 2024Option exercise(M)8K—$023K
Jun 14, 2024Option exercise(M)2K—$02K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-075075) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML